The American Academy of Orthopaedic Surgeons (AAOS) Registry Program released the American Joint Replacement Registry (AJRR) 2024 Annual Report Supplement during the AAOS 2025 Annual Meeting in San Diego.
“The 2024 AJRR Supplement provides important information to stakeholders as it underscores the registry’s growth and ability to track more nuanced outcomes for complex problems,” said Jeffrey Benjamin Stambough, MD, FAAOS, via press release. He is an AJRR Steering Committee member and co-editor of the AJRR Supplement. “The investigation of specific outcomes for Debridement, Antibiotics, and Implant Retention (DAIR) for periprosthetic joint infection diagnoses provides a clearer picture of the mid-to-long-term success of such an intervention. Additionally, through this report, we have provided a poignant case example that showcases the power of the registry to track specific implant survivorship and note trends if certain constructs fall below the accepted standard.”
To read and download the AJRR 2024 Annual Report Supplement, visit AAOS.org.
Source: American Academy of Orthopaedic Surgeons. American Joint Replacement Registry (AJRR) 2024 Annual Report. Published March 10, 2025. Available at https://www.aaos.org/registries/publications/ajrr-annual-report/. Accessed March 15, 2025.
